Press Releases April 8, 2026 04:05 PM

Orion Group Holdings to Report First Quarter 2026 Financial Results on Tuesday, April 28, 2026

Orion Group Holdings to announce Q1 2026 earnings and host a conference call on April 28-29, 2026.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
ORN

Orion Group Holdings, a specialty construction company focused on infrastructure, industrial, and building sectors, will release its first quarter 2026 financial results after market close on April 28, 2026. The company plans to discuss these results in a conference call and webcast with analysts and investors the following day.

Orion Group Holdings to Report First Quarter 2026 Financial Results on Tuesday, April 28, 2026
ORN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Orion Group Holdings operates marine and concrete construction segments serving multiple geographic regions including the US, Canada, and the Caribbean.
  • The company provides a broad range of services including dredging, marine pipeline construction, environmental dredging, and turnkey concrete services for large commercial projects.
  • The first quarter financial results release and subsequent conference call offer transparency and communication with investors and analysts about the company’s recent performance and outlook.

HOUSTON, April 08, 2026 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN), a leading specialty construction company, today announced that it will issue its first quarter 2026 financial results after the close of the stock market on Tuesday, April 28, 2026.

A conference call and audio webcast with analysts and investors will be held the next day, Wednesday, April 29, 2026, at 9:00 a.m. Eastern Time/8:00 a.m. Central Time to discuss the results.

  • Live conference call: 844-481-2994
  • Live and archived webcast: Orion Group Holdings, Inc. - Investor Relations & Shareholder Contact (oriongroupholdingsinc.com)

About Orion Group Holdings, Inc.

Orion Group Holdings, Inc., a leading specialty construction company serving the infrastructure, industrial and building sectors, provides services both on and off the water in the continental United States, Alaska, Hawaii, Canada and the Caribbean Basin through its marine segment and its concrete segment. The Company's marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services, including place and finish, site prep, layout, forming, and rebar placement for large commercial, structural and other associated business areas. The Company is headquartered in Houston, Texas with regional offices strategically located across its operating areas. (oriongroupholdingsinc.com)

Contact:

Margaret Boyce
346-278-3762
[email protected]

Source: Orion Group Holdings, Inc.        


Risks

  • The company's financial results could reveal challenges related to economic conditions impacting infrastructure and construction demand, affecting revenue and profitability.
  • Geographical and operational exposure to complex marine projects and environmental regulations could introduce uncertainties and cost overruns.
  • Market reaction risks exist if the financial results fail to meet investor expectations, potentially affecting stock price and investor sentiment.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026